These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 3404440)

  • 1. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers.
    Thompson KA; Iansmith DH; Siddoway LA; Woosley RL; Roden DM
    J Pharmacol Exp Ther; 1988 Mar; 244(3):950-5. PubMed ID: 3252042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative electrophysiological effects of propafenone, 5-hydroxy-propafenone, and N-depropylpropafenone on guinea pig ventricular muscle fibers.
    Rouet R; Libersa CC; Broly F; Caron JF; Adamantidis MM; Honore E; Wajman A; Dupuis BA
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):577-84. PubMed ID: 2478771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of 5-hydroxypropafenone on guinea pig ventricular muscle fibers.
    Valenzuela C; Delgado C; Tamargo J
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):523-9. PubMed ID: 2447400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental electrophysiologic effects of propafenone and 5-hydroxypropafenone on the canine cardiac Purkinje fiber.
    Case CL; Ravin RR; Maheshwari R; Gillette PC; Hewett KW
    Dev Pharmacol Ther; 1991; 17(1-2):24-34. PubMed ID: 1811919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonic and phasic Vmax block induced by 5-hydroxypropafenone in guinea pig ventricular muscles.
    Valenzuela C; Delpón E; Tamargo J
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):423-31. PubMed ID: 2465442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic effects of alprafenone on canine cardiac tissue.
    Anyukhovsky EP; Rosen MR
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):411-9. PubMed ID: 7528297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of propafenone on slow response action potential and the slow inward current of the myocardium].
    Xu YQ; Liu YM; Gao RB; Mei YA; Xu JM
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):138-40. PubMed ID: 2946151
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrophysiological effects of propafenone on isolated guinea-pig ventricular muscle and sheep Purkinje fibres.
    Tamargo J; Delgado C
    Eur J Pharmacol; 1985 Dec; 118(3):331-40. PubMed ID: 4085559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
    von Philipsborn G; Gries J; Hofmann HP; Kreiskott H; Kretzschmar R; Müller CD; Raschack M; Teschendorf HJ
    Arzneimittelforschung; 1984; 34(11):1489-97. PubMed ID: 6543124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of McN-4130, a new antiarrhythmic compound, on isolated cardiac tissue.
    Damiano BP; Brannan MD
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):498-508. PubMed ID: 2447397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
    Damiano BP; Stump GL; Yagel SK
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects of propafenone on canine ischemic cardiac cells.
    Zeiler RH; Gough WB; El-Sherif N
    Am J Cardiol; 1984 Aug; 54(3):424-9. PubMed ID: 6465028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic effects of AHR 10718 on isolated cardiac tissues.
    Damiano BP; Le Marec H; Rosen MR
    Eur J Pharmacol; 1985 Feb; 108(3):243-55. PubMed ID: 3838726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog.
    Boucher M; Chassaing C; Hamel JD; Poirier JM
    Eur J Pharmacol; 1996 Nov; 315(2):171-7. PubMed ID: 8960881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations.
    Sunami A; Sawanobori T; Adaniya H; Hiraoka M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):323-30. PubMed ID: 1961258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
    Zaza A; Malfatto G; Schwartz PJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):336-43. PubMed ID: 8169840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of MDL 11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalol.
    Li T; Carr AA; Dage RC
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):917-23. PubMed ID: 1704984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of propafenone on sinus nodal and ventricular automaticity: in vitro and in vivo correlation.
    Katoh T; Karagueuzian HS; Sugi K; Ohta M; Mandel WJ; Peter T
    Am Heart J; 1987 Apr; 113(4):941-52. PubMed ID: 3565244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.